Resources from the same session
Introduction by the chair
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Yes
Presenter: Jonas Bergh
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast
Q&A
Presenter: Sibylle Loibl
Session: Do we need checkpoint inhibitors as part of the neoadjuvant therapy in TNBC?
Resources:
Slides
Webcast